Gene therapy will not reach its full potential as a transformative treatment for genetic diseases unless manufacturing ...

Preclinical findings are the basis for an upcoming Phase II clinical trial evaluating psilocybin during chemotherapy in ...

Venetoclax, a cancer drug that inhibits BCL-2, reduced the intact SIV reservoir in macaques and may inform future HIV cure ...

Experiments revealed the profound influence of microenvironmental context on uropathogenic E. coli infection dynamics and ...

The DARPA project had the potential to improve athletic performance and help treat conditions involving a lack of oxygen in ...

New research models plasmid competition in E. coli, with implications for biotechnology, antibiotics, and probiotics.

The Boulder, CO, site is scheduled to become operational in the second half of 2027, following completion and qualification.

Cell and gene therapies have entered a new phase of maturity. Scientific innovation continues at an unprecedented pace, but ...

Study identifies a gene that could potentially be targeted in human pancreatic duct cells to replenish β cell mass for ...

Findings suggest that SARS-CoV-2 infection can activate an immune program that closely resembles those involved in ...

Manufacturing activities are expected to include process optimization, scale-up, analytical qualification, and potency assay ...